Anja Scholzen

Anja Scholzen is a highly experienced Senior Scientist specializing in biomarker development in immunology. Currently at Byondis since June 2021, Anja oversees biomarker strategies for immuno-oncology projects and manages assay development and validation for first-in-human trials. Previously at Innatoss Laboratories from July 2016 to June 2021, Anja served as the principal investigator on US Defense Threat Reduction Agency-funded projects and contributed to Horizon2020 initiatives, publishing eight peer-reviewed papers. Anja's academic background includes a postdoctoral researcher position at Radboud University Nijmegen Medical Centre, focused on malaria immunology, as well as research roles at Monash University and the University of Melbourne, culminating in a PhD in Immunology. Anja has also engaged in journalism and publishing prior to a dedicated career in scientific research.